Talaromyces marneffei (Segretain et al.) Samson et al.
商品貨號
B220182
Deposited As
Penicillium marneffei Segretain et al.
Strain Designations
NIHT 38-0141-25 [IFM 47279]
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Medium
ATCC® Medium 324: Malt extract agar
ATCC® Medium 336: Potato dextrose agar (PDA)
ATCC® Medium 2003: Czapek yeast extract agar
Growth Conditions
Temperature: 24°C to 26°C
Atmosphere: Typical aerobic
Name of Depositor
Y Mikami
Special Collection
NCRR Contract
Chain of Custody
ATCC <-- Y Mikami <-- N. Poonwan
Isolation
Human blood of male (HIV status unknown), Chiang Rai Hospital, Thailand 6/13/95
References
Y Mikami, personal communication
Uehara M, et al. Penicillium marneffei isolated from a Thai AIDS patient with fungemia. Nippon Ishinkin Gakkai Zasshi 49: 205-209, 2008.
Lasker BA. Nucleotide sequence-based analysis for determining the molecular epidemiology of Penicillium marneffei. J Clin Microbiol 44: 3145-3153, 2006. PubMed: 16954240
